期刊文献+

铜绿假单胞菌诱导气道上皮细胞产生MUC5AC的分子机制

Molecular mechanism of pseudomonas aeruginosa stimulating MUC5AC production in airway epithelial cells
下载PDF
导出
摘要 目的探讨铜绿假单胞菌(Pseudomonas aeruginosa,Pa)诱导气道上皮细胞表达产生粘蛋白MUC5AC的影响,并探讨其可能的分子机制。方法体外培养NCI-H292细胞,用Pa感染后,采用ELISA检测MUC5AC的产生情况;并用商品化的MMP-9活性检测试剂盒检测其产生以及酶活性情况。同时,采用EGFR,PI3K,NADPH,ROS和MMP特异性抑制剂AG1478,LY294002,DPI,NAC和GM6001预处理NCI-H292细胞,观察MUC5AC以及MMP-9的产生情况。结果 Pa能以时间依赖性方式诱导NCI-H292细胞产生MMP-9,并增加其活性。EGFR活化后,经PI3K途径激活Rac1并诱导MMP-9的表达,最终诱导MUC5AC产生。结论 Pa经EGFR/PI3K/Rac1/NADPH/ROS/MMP-9通路诱导NCI-H292细胞产生MUC5AC。 Objective To investigate the molecular mechanism of Pseudomonas aeruginosa (Pa)-induced mucus MUC5AC expression in the human airway cells NCI-H292. Methods Bronchial epithelial NCI-H292 cells cells were cultured in vitro, MUC5AC production after stimulation with Pa was analyzed by enzyme-linked immunosorbent assay (ELISA). Production and activity of matrix metalloproteinase 9(MMP-9)was analyzed by a commercial kit (MMP-9 Activity Biotrak Assay System kit). For inhibition study, cells were pretreated with different inhibitors such as AG1478, LY294002,DPI,NAC and GM6001 before stimulation,which specifically inhibit EGFR,PI3K,NADPH,ROS,and MMP,and then production of MUC5AC or MMP-9 were annualized. Results Pa-stimulated NCI-H292 cells exhibited a time-dependent increase in total MMP-9 levels, and time-dependent increasing levels of active MMP-9. EGFR and PI3K mediated-Racl activation was required for an optimal secretion and activation of MMP-9,and EGFR is necessary for Pa to activate Racl. NADPH-generated ROS act downstream of Racl to promote MMP-9 secretion and activation, and then stimulated MUC5AC production. Conclusion EGFR/PI3K/Racl/NADPH/ROS/MMP-9 regulate MUC5AC production in Pa -challenged NCI-H292 cells.
出处 《中国现代医生》 2013年第29期1-3,共3页 China Modern Doctor
基金 湖南省衡阳市科学技术发展计划项目(012KJ28)
关键词 铜绿假单胞菌 基质金属蛋白酶-9 MUC5AC Pseudomonas aeruginosa Matrix metalloproteinase 9 MUC5AC
  • 相关文献

参考文献9

  • 1Tanabe N,Muro S, Hirai T,et al. Impact of exaeerbations on emphy- sema progression in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med,2011,183(12) : 1653-1659.
  • 2Evans CM,Koo JS. Airway mucus:the good,the bad,the sticky[J]. Pharmacol Ther, 2009, 121 (3) : 332-348.
  • 3Rogers DF. The role of airway secretions in CDPD:pathophysiology, epidemiology and pharmacotherapeutic options[J]. COPD,2005,2 (3): 341-353.
  • 4Rogers DF,Barnes PJ. Treatment of airway nmcus hyperseeretion[J]. Ann Med,2006,38(2) : 116-125.
  • 5Rose MC,Voynow JA. Respiratory tract mucin genes and mucin gly- coproteins in heahh and disease[J]. Physiol Rev,2006,86 ( 1 ) :245- 278.
  • 6Shen H,Yoshida H,Yan F,et al. Synergistic induction of MUC5AC mucin by nontypeable Haemophilus influenzae and Streptococcus pneumeniae [J]. Biochem Biephys Res Commun,2008,365 (4) :795 - 800.
  • 7Sadowska AM. N-Acetylcysteine mueolysis in the management of chronic obstructive puhnonary disease[J]. Ther Adv Respir Dis,2012, 6(3 ) : 127-135.
  • 8Bokoch GM. Regulation of innate immunity by Rho GTPases[J]. Trends Cell Bio1,2005,15(3) : 163-171.
  • 9Zhang P,Summer WR,Bagby GJ,et al. Innate immunity amt tml- monary host defense[J], lmmunol Rev, 2000,173 (6) : 39-51.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部